Skip to main content
. Author manuscript; available in PMC: 2011 Oct 13.
Published in final edited form as: Appl Radiat Isot. 2007 Aug 17;66(3):278–287. doi: 10.1016/j.apradiso.2007.07.029

Figure 2.

Figure 2

Antibody characterization. 2a. EIA of 124I-JAA-F11 labeled by Iodogen and Bolton Hunter method showing loss of immunoreactivity of the labeled antibody with the Iodogen method and preservation of JAA-F11 binding with the Bolton Hunter method. Error bars represent +/− 1 SEM. 2b. Indirect Cell EIA to test the expression of TF-Ag on cancer cell lines, showing significant JAA-F11 binding to 4T1 cells (p = 0.019 versus Myeloma cells) and not to CMS4 cells (p = 0.279 versus Myeloma cells).